Related Experiment Video
Updated: Feb 28, 2026

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
DUSP26 protects against acute kidney injury by dephosphorylating p53 at serine 312
Ying Fu1,2,3, Yu Xiang1, Yun Han1
1Department of Nephrology, Hunan Key Laboratory of Kidney Disease and Blood Purification, Institute of Nephrology, The Second Xiangya Hospital at Central South University, Changsha, China.
Abstract:
Acute kidney injury (AKI) remains a leading cause of morbidity and mortality, yet the molecular pathways driving kidney tubule damage in AKI are not fully understood. Here, we report dual-specificity phosphatase 26 (DUSP26) as a critical regulator of kidney tubule injury in AKI. In our study, DUSP26 expression was markedly reduced in kidney biopsies from AKI patients of both sexes and in male murine models of cisplatin nephrotoxic and ischemic AKI. This down-regulation was driven by hypermethylation of the gene promoter of DUSP26 in kidney tubular cells. Loss of DUSP26 exacerbated tubular damage, whereas knock-in of DUSP26 specifically in kidney proximal tubule cells conferred protection. Mechanistically, DUSP26 directly bound to p53 to dephosphorylate it at serine 312, dampening the transcriptional activity of p53 towards cell death genes. Pharmacologic inhibition of DUSP26 sensitized kidneys to AKI, whereas DUSP26 overexpression was protective. Pharmacologic inhibition of DUSP26 also exacerbated ischemia-reperfusion injury in the liver. These findings uncover DUSP26 as a key phosphatase guarding against tissue injury by dephosphorylating p53 at serine 312, and highlight the DUSP26-p53 axis as a promising therapeutic target.
Insights
Dual-specificity phosphatase 26 (DUSP26) protects against acute kidney injury (AKI) by regulating p53. Reduced DUSP26 expression exacerbates kidney tubule damage, while its restoration offers protection, revealing a potential therapeutic target.
Area of Science:
- Nephrology
- Molecular Biology
- Biochemistry
Background:
- Acute kidney injury (AKI) is a major cause of patient mortality.
- The molecular mechanisms underlying kidney tubule damage in AKI are not fully elucidated.
- Identifying novel regulators of AKI is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the role of dual-specificity phosphatase 26 (DUSP26) in kidney tubule injury during AKI.
- To elucidate the molecular mechanisms by which DUSP26 influences AKI.
- To evaluate the therapeutic potential of targeting the DUSP26-p53 pathway in AKI.
Main Methods:
- Analysis of DUSP26 expression in human kidney biopsies and murine AKI models.
- Investigation of DUSP26 promoter methylation in kidney tubular cells.
- Assessment of DUSP26 function using gene knockout and knock-in models.
- Biochemical assays to determine DUSP26 interaction with p53.
- Pharmacological manipulation of DUSP26 activity in AKI and liver ischemia-reperfusion injury models.
Main Results:
- DUSP26 expression is significantly reduced in kidney biopsies from AKI patients and in murine AKI models.
- Reduced DUSP26 expression in AKI is associated with hypermethylation of its gene promoter.
- Loss of DUSP26 exacerbates kidney tubule injury, whereas DUSP26 expression confers protection.
- DUSP26 directly dephosphorylates p53 at serine 312, reducing p53-mediated apoptosis.
- Pharmacological inhibition of DUSP26 worsens AKI and liver injury, while DUSP26 overexpression is protective.
Conclusions:
- DUSP26 is a critical regulator of kidney tubule injury in AKI.
- The DUSP26-p53 signaling axis plays a key role in protecting against AKI.
- DUSP26 dephosphorylates p53 to dampen pro-apoptotic signaling.
- Targeting the DUSP26-p53 pathway represents a promising therapeutic strategy for AKI.
More Related Videos
Related Concept Videos
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
PI3K/mTOR/AKT Signaling Pathway
Acute Kidney Injury II: Pathophysiology
The JAK-STAT Signaling Pathway

